We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONDW
276
DELISTED
Sonder Holdings Inc Warrants
SONDW
$38.6K ﹤0.01%
+477,389
New +$72.5K
ACAXR
277
DELISTED
Alset Capital Acquisition Corp Right
ACAXR
$37.5K ﹤0.01%
249,978
+3,485
+1% +$490
CGC
278
PUT
Canopy Growth
CGC
$418M
$37.3K ﹤0.01%
+5,000
New +$154K
ATAKR
279
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
$37.2K ﹤0.01%
285,859
+51,510
+22% +$3.87K
FITB
280
CALL
Fifth Third Bancorp
FITB
$51.9B
$35.4K ﹤0.01%
+101,000
New +$3.45M
SPY icon
281
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$35.2K ﹤0.01%
+15,500
New +$5.96M
ADTHW
282
DELISTED
AdTheorent Holding Co Warrants
ADTHW
$34.9K ﹤0.01%
+348,785
New +$55.5K
TGTX icon
283
CALL
TG Therapeutics
TGTX
$7.68B
$34.9K ﹤0.01%
+82,000
New +$595K
WINVR
284
DELISTED
WinVest Acquisition Corp. Right
WINVR
$34.6K ﹤0.01%
476,847
RONI.WS
285
DELISTED
Rice Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
RONI.WS
$34.3K ﹤0.01%
+27,453
New +$12.4K
MCAGR
286
DELISTED
Mountain Crest Acquisition Corp. V Right
MCAGR
$34.2K ﹤0.01%
+149,900
New +$26.3K
META icon
287
CALL
Meta Platforms (Facebook)
META
$1.55T
$34K ﹤0.01%
+10,000
New +$1.17M
LNZAW icon
288
LanzaTech Global Warrant
LNZAW
$33.5K ﹤0.01%
139,622
+49,925
+56% +$10.7K
DAVEW icon
289
Dave Inc Warrants
DAVEW
$13.5M
$33.5K ﹤0.01%
1,015,053
+991,626
+4,233% +$37.7K
CLRCR
290
DELISTED
ClimateRock Right
CLRCR
$33.4K ﹤0.01%
278,586
+16,300
+6% +$1.87K
GSAT icon
291
Globalstar
GSAT
$10.8B
$33.3K ﹤0.01%
1,667
-2,333
-58% -$61.3K
JWSM.WS
292
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$33K ﹤0.01%
507,670
+93,353
+23% +$8.04K
RWODR
293
DELISTED
Redwoods Acquisition Corp. Rights
RWODR
$32K ﹤0.01%
200,200
-171,091
-46% -$21.4K
EACPW
294
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$31.9K ﹤0.01%
1,061,193
+710,923
+203% +$22.5K
HLLY.WS
295
DELISTED
Holley Inc Warrants
HLLY.WS
$31K ﹤0.01%
114,673
-78,187
-41% -$35.4K
PPHPR
296
DELISTED
PHP Ventures Acquisition Corp. Rights
PPHPR
$30.9K ﹤0.01%
176,501
-24,050
-12% -$2.26K
ZLSWW
297
DELISTED
Zalatoris II Acquisition Corp Warrant
ZLSWW
$30.1K ﹤0.01%
186,044
+169,378
+1,016% +$17K
MAPS
298
DELISTED
WM TECHNOLOGY INC A
MAPS
$28.8K ﹤0.01%
28,562
JUN.WS
299
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$28.5K ﹤0.01%
174,380
+23,607
+16% +$2.87K
GROV.WS
300
DELISTED
Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50
GROV.WS
$27.3K ﹤0.01%
+272,709
New +$20.3K

Similar funds

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.